v3.26.1
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss for the period $ (8,281) $ (6,754)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Amortization and depreciation 298 151
Share based compensation 1,875 3,869
Gain on revaluation of warrant liability (400)
Gain from revaluation of investment in associate (7)
Change in long term trade receivables (1,124)
Change in severance liability (3)
Change in inventory (1,645) 15
Change in trade receivables (503) (121)
Change in other accounts receivables (544) (268)
Accrued interest on loans and leases 64 14
Change in accounts payable 784 (357)
Change in other accounts payable (575) 42
Net cash used in operating activities: (9,658) (3,812)
Cash flows from investing activities    
Investment in short-term deposits (89) (10,650)
Investment in financial assets 14,978
Purchase of property, plant and equipment (344) (46)
 Net of cash flows from investing activities  14,545 (10,696)
Cash flows from financing activities    
Proceeds from the issuance of shares and warrants, net 27,395
Exercise of warrants 946
Lease payments (260) (81)
Proceeds from exercise of options 12 1,020
Purchase of treasury stock (3,479)
Repayment of loans (1) (771)
Transactions with non-controlling interests (1,850)
Net of Cash flows from financing activities   (2,782) 25,713
Decrease in cash and cash equivalents 2,105 11,205
Effect of changes in foreign exchange rates 578 (540)
Cash and cash equivalents at beginning of period 13,525 13,526
Cash and cash equivalents at end of period 16,208 24,191
Interest paid during the period 20 18
APPENDIX A: NON-CASH ACTIVITIES    
Recognition of a lease liability and right-of-use asset 1,716
Fair value of warrants exercise during the period $ 576